Hematopoietic system: Oxaliplatin has low hematological toxicity. During a monochemotherapy course, the administration of oxaliplatin can lead to the following unwanted effects; anaemia, leukopenia, granulocytopenia, thrombocytopenia, sometimes of grade 3 or 4 (Severity of grade; neutrophil count < 500/mm
2, platelet count <25,000/mm
3, hemoglobin <6.5 g/100 mL). The anticipated complications of Oxaliplatin overdose include myelosuppression, nausea, and vomiting, diarrhea and neurotoxicity.